Marketplace Logo Donate

Daily business news and economic stories from Marketplace

Senate Finance Committee to consider drug costs

A man looks at a pill bottle in a store.

Justin Sullivan/Getty Images

Subscribe to our Newsletters

Drug prices just keep rising – at five times the rate of inflation according to Gerard Anderson, professor at Johns Hopkins University who has been advising the Senate Finance Committee, which is scheduled to consider a bipartisan measure on Thursday.  He says the measure would add an out-of -pocket maximum for Medicare beneficiaries and force companies to pay money back if their prices rise above inflation. And, he says, it would, “keep the drug companies from raising their list prices.”

The Congressional Budget Office estimates this bill would save beneficiaries $27 billion. Rachel Sachs at Washington University in St. Louis says some Congress members oppose it because, ” telling pharmaceutical companies they can’t increase their prices as much as they want from year to year somehow is too much of a governmental role.”

The drug companies also don’t like it. Stacie Dusetzina professor at Vanderbilt University says that’s because the bill, “basically puts them on the hook for more spending.”

Whether this measure passes or not she says this issue isn’t likely to go away anytime soon.

What's Next

Latest Episodes From Our Shows

Listen
Sep 30, 2022
27:58
Listen
Sep 30, 2022
26:43
Listen
Sep 30, 2022
1:50
Listen
Sep 30, 2022
6:18
Listen
Sep 30, 2022
5:03
Listen
Sep 29, 2022
2:55
Listen
Aug 9, 2022
24:46
Exit mobile version